Skip to main content
Loading

SciTech Development

Monday, February 26, 2024
Uris
Oncology
SciTech is a clinical-stage oncology-focused drug delivery technology company. Our initial clinical trial is underway with IRB-approved sites at UPMC, Columbia University, MD Anderson, USC, U Michigan, and Karmanos Cancer Institute. SciTech's mission is to develop safe oncology therapeutics that significantly improve patient outcomes.
Speakers
Earle Holesapple, CEO - SciTech Development

State

Michigan

Country

United States

Website

http://www.scitechdevelopment.com www.scitechsdp.com

CEO/Top Company Official

Earle Holsapple

Lead Product in Development

ST-001 Nanofenretinide

Development Phase of Primary Product

Phase I

Number Of Unlicensed Products

1
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Media Partner


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP